• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Moderna Inc (NQ: MRNA )

    91.56 +4.72 (+5.43%)
    Streaming Delayed Price Updated: 11:26 AM EDT, Aug 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,512,494
    Open 87.02
    Bid (Size) 91.51 (1)
    Ask (Size) 91.62 (4)
    Prev. Close 86.84
    Today's Range 86.62 - 91.99
    52wk Range 62.55 - 170.47
    Shares Outstanding 384,000,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Pfizer and BioNTech's Combo Shot Missed the Mark. Is It Time to Sell?
    A clinical-trial failure for Pfizer and BioNTech means Moderna is leading the race to develop a combo shot for the flu and COVID-19. 
    Via The Motley Fool
    Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Moderna and Sprinklr and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire

    Performance

    YTD
    -18.62%
    -18.62%
    1 Month
    -24.42%
    -24.42%
    3 Month
    -35.07%
    -35.07%
    6 Month
    +5.25%
    +5.25%
    1 Year
    -17.58%
    -17.58%

    More News

    Read More
    MRNA Shareholder Notice: Robbins LLP Reminds Investors of the Class Action Filed Against Moderna, Inc.
    From Robbins LLP
    Via Business Wire
    Demystifying Moderna: Insights From 11 Analyst Reviews
    Via Benzinga
    Moderna and Coursera Launch Free Course on mRNA Technology
    Via ACCESSWIRE
    Smart Money Is Betting Big In MRNA Options
    Via Benzinga
    ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Moderna, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    Pfizer, BioNTech's COVID-19/Flu Combo Vaccine Fails To Meet Key Goal In Late-Stage Study
    Via Benzinga
    Exposures COVID-19
    MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    MODERNA ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Moderna, Inc. and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Market Whales and Their Recent Bets on MRNA Options
    Via Benzinga
    Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA
    From Robbins LLP
    Via Business Wire
    Stockholder Alert: Robbins LLP Informs Moderna, Inc. Stockholders that a Shareholder Filed a Class Action Against MRNA
    From Robbins LLP
    Via GlobeNewswire
    MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From Schall Law
    Via GlobeNewswire
    What the Options Market Tells Us About Moderna
    Via Benzinga
    Struggling COVID-19 Vaccines From AstraZeneca, BioNTech/Pfizer, Moderna Cut Incidence Of Arterial Thromboses That Cause Heart Attacks, Strokes, British Study Shows
    Via Benzinga
    Exposures COVID-19
    Long Covid Remains Diagnostic Mystery, Diagnosis Remains Elusive; National Institutes of Health-Funded Study Shows
    Via Benzinga
    Exposures COVID-19
    3 Biotech Stocks Poised for a Comeback After Last Week’s Market Meltdown
    Via InvestorPlace
    ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Moderna, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – MRNA
    From The Rosen Law Firm PA
    Via GlobeNewswire
    $1000 Invested In This Stock 5 Years Ago Would Be Worth $6,300 Today
    Via Benzinga
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Novavax Plunges on Earnings Miss: Falling Knife or Buying Opp?
    Via MarketBeat
    Exposures COVID-19
    MRNA Investors Have Opportunity to Lead Moderna, Inc. Securities Fraud Lawsuit with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Expanding the Cloud for AI
    Via The Motley Fool
    Topics Artificial Intelligence
    Exposures Artificial Intelligence
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.